Prodia Diagnostic Line Tbk vs Super Bank Indonesia Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 474.07B, 21.23M 24h volume), while Super Bank Indonesia Tbk. trades at Rp570 (market cap 19.8T, 51.07M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 41.8× Prodia Diagnostic Line Tbk's market cap, and Super Bank Indonesia Tbk. is more actively traded (51.07M versus 21.23M). Which is the better fit depends on your goals.
| PRDL | SUPA | |
|---|---|---|
Market Cap | 474.07B | 19.8T |
Volume | 21.23M | 51.07M |
Lot | 212.3K | 510.7K |
Turnover | 5.77B | 29.1B |
Average Price | 271.63 | 569.76 |
Value | 5.77B | 29.1B |
Indicative Equilibrium Price | 270 | 570 |
Indicative Equilibrium Volume | 2.21K | 29.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →